Natrexone/BSA is an antigen-adjuvant conjugate of Natrexone and bovine serum albumin (BSA). Conjugating the antigen with a protein adjuvant boosts the production of antigen-specific antibodies in vaccine models. This conjugate does not affect protein folding or alter primary epitopes, and it enhances cross-presentation and the production of antigen-specific T cells.